国家基本药物目录(2018年版)收载药品(西药部分)在河南省医药采购平台的挂网情况分析

曹凯; 钱佩佩; 刘伟; 杨健; 杨帅; 赵亮; 兰为民; 兰丙欣<sup>*</sup>

引用本文:	曹凯,钱佩佩,刘伟,杨健,杨帅,赵亮,兰为民,兰丙欣.国家基本药物目录(2018年版)收载药品(西药部分)在河南省医药采购平台的挂网情况分析[J].中国现代应用药学,2020,37(19):2414-2419.
	CAO Kai,QIAN Peipei,LIU Wei,YANG Jian,YANG Shuai,ZHAO Liang,LAN Weimin,LAN Bingxin.Analysis of Online Bidding Procurement of Western Medicines in National Essential Medicines List (2018 Edition) on Henan Provincial Pharmaceutical Procurement Platform[J].Chin J Mod Appl Pharm(中国现代应用药学),2020,37(19):2414-2419.

【打印本页】【HTML】【下载PDF全文】【查看/发表评论】【EndNote】【RefMan】【BibTex】

←前一篇|后一篇→

过刊浏览高级检索

本文已被：浏览 12744次下载 6576次	码上扫一扫！
分享到：微信更多字体:加大+\|默认\|缩小-
国家基本药物目录(2018年版)收载药品(西药部分)在河南省医药采购平台的挂网情况分析
曹凯¹, 钱佩佩¹, 刘伟², 杨健³, 杨帅⁴, 赵亮¹, 兰为民¹, 兰丙欣¹
1.河南科技大学附属许昌市中心医院, 河南许昌 461000;2.郑州大学药学院, 郑州 450001;3.商丘医学高等专科学校, 河南商丘 476100;4.国药控股河南股份有限公司许昌分公司, 河南许昌 461000

摘要:

目的为国家基本药物目录的动态调整和优化提供参考和建议。方法对国家基本药物目录（2018年版）收载药品（西药部分）在河南省公共资源交易中心医药采购平台中的挂网情况进行统计分析，筛选出未挂网和独家挂网的基本药物。结果 2018年版目录中共有146个规格（涉及100个品种）未在河南省公共资源交易中心医药采购平台中挂网。其中，整个品种未挂网的国家基本药物共有10个，某一大类剂型整体未挂网的国家基本药物共有4个。另外，整个品种名称下只有1个规格挂网，且为生产企业独家挂网的国家基本药物共有44个。结论造成国家基本药物在整个河南省未挂网采购的原因可能与药品供应出现短缺或临床实际需求减少有关。对于易发生短缺的基本药物，医疗机构和各级卫生健康行政部门应加强监测和分类应对。而对于临床实际需求减少，经评价后认为不适宜作为国家基本药物的，建议在国家基本药物目录动态调整时予以调出。

关键词: 国家基本药物目录集中采购挂网药品短缺

DOI：10.13748/j.cnki.issn1007-7693.2020.19.021

分类号:R954

基金项目:

Analysis of Online Bidding Procurement of Western Medicines in National Essential Medicines List (2018 Edition) on Henan Provincial Pharmaceutical Procurement Platform

CAO Kai¹, QIAN Peipei¹, LIU Wei², YANG Jian³, YANG Shuai⁴, ZHAO Liang¹, LAN Weimin¹, LAN Bingxin¹

1.Xuchang Central Hospital Affiliated to Henan University of Science and Technology, Xuchang 461000, China;2.College of Pharmacy, Zhengzhou University, Zhengzhou 450001, China;3.Shangqiu Medical College, Shangqiu 476100, China;4.Sinopharm Holding Henan Co., Ltd., Xuchang Branch, Xuchang 461000, China

Abstract:

OBJECTIVE To provide references and suggestions for the dynamic adjustment and optimization of National Essential Medicines List. METHODS Statistics and analysis were carried out of the online bidding procurement of the western medicines in National Essential Medicines List(2018 Edition) on the Pharmaceutical Procurement Platform of Henan Province Public Resources Trading Center. Screen out those that could not be procured online and could be procured from only one manufacturer. RESULTS A total of 146 strengths of 100 medicines in National Essential Medicines List(2018 Edition) could not be procured on the Henan Province Pharmaceutical Procurement Platform. Among them, 10 national essential medicines involving their all dosage forms and formats could not be procured online. One certain main sort of dosage forms of 4 national essential medicines could not be procured online. Besides, for 44 national essential medicines, there were only one strength can be procured from only one manufacturer. CONCLUSION Reasons for national essential medicines cannot be procured on the Henan Province Pharmaceutical Procurement Platform may be the shortage of pharmaceutical supplies or the reduction of clinical need. As to supply shortage, medical institutions and health administrative departments should strengthen monitoring and classified response. Meanwhile, medicines assessed to be not suitable as national essential medicines shall be removed from the National Essential Medicines List in subsequent dynamic adjustments.

Key words: national essential medicines list centralized procurement online bidding drug shortage